JOIN US IN LORNE FOR THE 37TH ANNUAL
LORNE CANCER CONFERENCE

On behalf of the Organising Committee, we would like to invite you to support the 37th Lorne Cancer Conference, being held from Thursday 13th to Saturday 15th of February 2025.

If you are a past participant, you will be aware of the history, ambience and vibrancy of this meeting. Immediately following the Lorne Proteins meeting, Lorne Cancer has a strong international and national scientific content and attracts a capacity audience of up to 500 delegates. These delegates represent many of the major hospitals, universities, research institutes and biotechnology companies within Australia.

Notably, along with the usual representation of biomedical research leaders from across Australia, an increasing proportion of these delegates includes clinician scientists and clinical opinion leaders to facilitate translational and clinical aspects of the meeting. Thus, there are excellent opportunities for pharmaceutical companies to interact directly with key decision makers and influencers, to strengthen their positions in the industry, to showcase their products or services face-to-face, and develop new partnerships and networks with a motivated and targeted audience.

One of the hallmarks of the meeting over many years has been the friendly and frequent interactions between delegates and the companies who supply equipment, reagents and pharmaceuticals. In 2024 we envisage having a full complement of international speakers and in-person delegates, therefore opportunities for the meeting’s sponsors to advertise and interact will be facilitated by numerous planned sessions.

We look forward to working with you to maximize your experience and benefit from Lorne Cancer 2025, which is again being managed by ASN, and to seeing you in Lorne!

Prof Jane Visvader and Prof Wayne Tilley
Co-convenors, Lorne Cancer Conference 2025